Irhythm Holdings vs Myriad Genetics
Irhythm Holdings and Myriad Genetics are similar in size: $747m and $825m of revenue in their latest fiscal years. Irhythm Holdings grew faster (26.2% against -1.6%). Irhythm Holdings kept more of each dollar of sales as profit: a net margin of -6.0% against -44.4%. Myriad Genetics carries less debt relative to equity (34.0% against 425.2%).
| Latest fiscal year | Irhythm HoldingsIRTC, 2025 | Myriad GeneticsMYGN, 2025 |
|---|---|---|
| Revenue | $747m | $825m |
| Revenue growth | 26.2% | -1.6% |
| Net income | −$44.6m | −$366m |
| Operating margin | -7.7% | -47.0% |
| Net margin | -6.0% | -44.4% |
| Return on equity | -36.6% | -68.5% |
| Free cash flow | $34.5m | $1.8m |
| Cash | $236m | $150m |
| Total debt | $650m | $125m |
| Debt to equity | 425.2% | 34.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $0 | — |
| Employees | 2,400 | 2,700 |
| Market value | $4.13bn | $567m |
| Price vs our value range | — | — |
| Moat score | 34 (Weak) | 26 (Weak) |
| Insider trades, 12 months | 1 buys, 65 sales | 5 buys, 1 sales |